(VIANEWS) – Shares of Castle Biosciences (NASDAQ: CSTL) dropped by a staggering 22.7% in 14 days from $21.23 to $16.41 at 13:44 EST on Tuesday, after five consecutive sessions in a row of losses. NASDAQ is rising 2.82% to $11,102.40, following the last session’s upward trend.
Castle Biosciences’s last close was $16.00, 79.73% under its 52-week high of $78.92.
Today’s last reported volume for Castle Biosciences is 277481 which is 27.55% below its average volume of 383011.
The company’s growth estimates for the ongoing quarter and the next is a negative 114.3% and a negative 68.1%, respectively.
Castle Biosciences’s Revenue
Year-on-year quarterly revenue growth grew by 44.7%, now sitting on 94.08M for the twelve trailing months.
Castle Biosciences’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.15%, a negative 0.84%, and a positive 5.09%, respectively.
Castle Biosciences’s highest amplitude of average volatility was 2.15% (last week), 4.59% (last month), and 5.09% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Castle Biosciences’s stock is considered to be overbought (>=80).
Castle Biosciences’s Stock Yearly Top and Bottom Value
Castle Biosciences’s stock is valued at $16.41 at 13:44 EST, below its 52-week low of $17.01.
Castle Biosciences’s Moving Average
Castle Biosciences’s worth is way below its 50-day moving average of $24.61 and way under its 200-day moving average of $44.68.
More news about Castle Biosciences (CSTL).